Jan Medical has developed the first and only portable brain sensing device designed to enable timely determination of ischemic stroke. A determination can be made in minutes. The device is also being evaluated for possible reliable detection of traumatic brain injuries, including concussions.
The Jan Medical device emits no energy into the brain and is therefore positioned as a “Non-Significant Risk” in clinical trial protocols. Continuous-monitoring options with the device include hours, days or weeks until the condition is resolved or requires intervention; all other brain assessment alternatives—such as CT and MRI—are mere “snapshots.”
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 06/01/11 | Series A | 3.15M | Unknown |
People
Paul Lovoi (President, CEO)
Ronald Trahan (President, CEO)
News
Funding Daily: Into the darkness
May 17, 2013 12:03 am
What do Star Trek and startups have in common? ‘Enterprise’ and ‘Data’ play a role in both and nerds everywhere… Continue reading ⟩
How we can realize Health IT’s full potential by looking at its setbacks
May 13, 2013 6:26 pm
Janice Nicholson is CEO of i2i Systems. As someone who has spent over 20 years focusing on the needs of… Continue reading ⟩
FCC’s new Digital Learning director puts focus on increasing Internet in schools
April 29, 2013 7:21 pm
The Federal Communications Commission announced today it has hired Michael Steffan as the director of digital learning. In his new role,… Continue reading ⟩